Saturday, September 14, 2013

Osipect

Osipect 
 • 0101030C-7106 
Osipect Syrup Composition: Each teaspoonful 5 ml) contains:
Glyceryt guaiacolats 50 mg
Potassium citrate 50 mg
Terbutaline sulphate 1.5 mg
Diphenhydramine HCI 14 mg
Properties:
Osipect syrup is characterized by combining four active ingredients which act synergistically to provide simultaneous expectorant, bronchodilator, and antihistaminic effects.
- Glyceryl guaiacolate (guaiaphenisin 
is a powerful expectorant for productive cough, it acts by increasing the volume and thus reducing the viscosity & tenacious sputum. It increases the efficiency of ciliary action to remove accumulated secretions from the trachea and bronchi.
- Terbutaline is one of the safest and most effective selective 2—agonists that relief bronchoapasm sasociated with cough and so facilitate expectoration.
- Diphenhydramine HCI is a potent antihistaminic agent with snticholinergic effects that is useful for symptomatic treatment of cough due to allergy.
- Citrates is a common ingredient in cough mixtures for its expectorant activity.
Indications 
& Usage: Osipect syrup is indicated in the treatment of productive and non-productive cough
associated with acute or chronic respiratory diseases such as:
- Acute and chronic bronchitis.
- Asthmatic bronchitis and other conditions associated with reversible airway obstruction.
- Cough associated wfth respiratory tract infections and related conditions as common cold, sinusitis and pharyngitis especially when these conditions are complicated by tenacious mucus.
- Pulmonary emphysema. 
Contra-Indications: - Known hypersensitivity to any of the drug components.
- Neonates and premature infants. 
Side Effects: Osipect syrup is well-tolerated but rarely transient and mild side effects may occur
with large doses
- Gastrointestinal discomfort, nausea and vomiting.
- Fine tremors, nervous tension and headache.
- Peripheral dilatation and palpitations. 
Drug Interactions: - Concurrent use of tricyclic antidepressants may potentiate the action of terbutaline on the vascular system.
- Concomitant administration of terbutaline and other )12.-agonists with corticosteroids, diuretics, or xanthines increases the risk of hypokalaemia.
- Terbutaline can decrease serum concentrations of digoxin.
- The sedative action of diphenhydramine may be potentiated by CNS depressants including alcohol, barbiturates, hypnotics, opioid analgesics and anxiolytic sedatives.
- Anticholinergic drugs may potentiate diphenhydrumines sntichlolinergic side effects. 
Warnings & Precautions: Osipect syrup should be used cautiously in the following cases:
- Hyperthyroidism.
- Arrhythmias, hypertension, and other cardiovascutar diseases.
- Pregnancy and lactation. 
Dosage & Administration: 1-2 teaspoonful 3-4 times daily. Packing: Bottle of 120 ml. Storage: Store below 30 C fffoorrt ue prsuuct wtuctr afrocto poor treemr, aod to cur rrrp&’t
contrary to irshochoos d dongorous for you.
- Fotow obtcdy the doctor’s roosculydon. fire roefirod of 
use and the
Instructions of t ho pharunoclot who soles the rnodicamoot.
- Tho doctor and the phamradot are woperte It medicine. irs henefits
cod rioko.
- On trot by poorsefi hrternrpt the period ot bwabnont prescribed for you.
- Do nut repeat the sewe prescdpbur, without consultng your doctor.
Keep medicamentnutotrhtdren wand
Cocrdctkab tout, euduws eu Unhncrkacpraorarute
Produced by: cheiritcet Industrtee Devetopment (CtO) - Gtza - ARE.